RD

Rathod Devalba

Active Director Director DIN 11384275
DIN 11384275 First appointment Nov 2025 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value •••• Premium profile

About Rathod Devalba

Data last updated:

Rathod Devalba is a Director at Apeka Organics Private Limited (since 2025). The company operates in Chemicals. Apeka Organics Private Limited reported revenue of ₹5,994 (FY 2025).

DIN 11384275
Primary Designation Director
Industry Chemicals
First Appointment 15 Nov 2025
Largest company Apeka Organics Private Limited · ₹5,994 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apeka Organics Private Limited U24230GJ2022PTC132716
Director15 Nov 2025₹5,994 (FY 2025)Active

Board colleagues of Rathod Devalba

NameDINCompanyDesignation
Ketankumar Rameshchandra Patel09510178Apeka Organics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Apeka Organics Private Limited
Premium access

Shareholding and investment profile for Rathod Devalba

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rathod Devalba

Rathod Devalba currently holds 1 directorship: Apeka Organics Private Limited (Director, since 15 Nov 2025, revenue ₹5,994 (FY 2025)).

Rathod Devalba was first appointed on 15 Nov 2025 as Director at Apeka Organics Private Limited.

The current boards of Rathod Devalba's companies include Ketankumar Rameshchandra Patel (Apeka Organics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available